132 related articles for article (PubMed ID: 32930135)
41. The evaluation of two genetic polymorphisms of paraoxonase 1 in patients with pulmonary embolism.
Basol N; Karakus N; Savas AY; Karakus K; Kaya İ; Karaman S; Yigit S
J Clin Lab Anal; 2018 Sep; 32(7):e22455. PubMed ID: 29682786
[TBL] [Abstract][Full Text] [Related]
42. [Investigation of the association between paraoxonase-1 gene polymorphisms and response to therapy in chronic hepatitis C patients].
Kıratlı K; Gül HC; Artuk C; Kozan S; Oztuna A; Tunca Y; Eyigün CP
Mikrobiyol Bul; 2014 Oct; 48(4):596-605. PubMed ID: 25492655
[TBL] [Abstract][Full Text] [Related]
43. Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies.
Fang DH; Fan CH; Ji Q; Qi BX; Li J; Wang L
Mol Biol Rep; 2012 Jun; 39(6):6801-9. PubMed ID: 22322559
[TBL] [Abstract][Full Text] [Related]
44. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults.
Voetsch B; Benke KS; Panhuysen CI; Damasceno BP; Loscalzo J
Arch Neurol; 2004 Mar; 61(3):351-6. PubMed ID: 15023811
[TBL] [Abstract][Full Text] [Related]
45. Tumor necrosis factor-alpha-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Yeh LS; Tsai CH
Fertil Steril; 2004 Oct; 82 Suppl 3():1177-81. PubMed ID: 15474092
[TBL] [Abstract][Full Text] [Related]
46. Paraoxonase 1 (PON1) Q192R and L55M Polymorphisms as Potential Predisposition Factors for Chronic Lymphocytic Leukemia.
Ioannidou A; Zachaki S; Daraki A; Margariti IM; Pantelia D; Diamantopoulou P; Sambani C; Roussou P; Manola KN
Anticancer Res; 2019 Jun; 39(6):2861-2869. PubMed ID: 31177124
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.
Rajković MG; Barišić K; Juretić D; Grubišić TŽ; Flegar-Meštrić Z; Rumora L
Clin Biochem; 2011 Aug; 44(12):964-8. PubMed ID: 21620813
[TBL] [Abstract][Full Text] [Related]
48. Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome.
Kordi-Tamandani DM; Hashemi M; Sharifi N; Kaykhaei MA; Torkamanzehi A
Mol Biol Rep; 2012 Feb; 39(2):937-43. PubMed ID: 21573798
[TBL] [Abstract][Full Text] [Related]
49. Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians.
Agrawal S; Tripathi G; Prajnya R; Sinha N; Gilmour A; Bush L; Mastana S
Indian J Med Sci; 2009 Aug; 63(8):335-44. PubMed ID: 19770524
[TBL] [Abstract][Full Text] [Related]
50. The Association between PON1 (Q192R and L55M) Gene Polymorphisms and Risk of Cancer: A Meta-Analysis Based on 43 Studies.
Pan X; Huang L; Li M; Mo D; Liang Y; Liu Z; Huang Z; Huang L; Liu J; Zhu B
Biomed Res Int; 2019; 2019():5897505. PubMed ID: 31467900
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of paraoxonase 1 polymorphisms in patients with bipolar disorder.
Küçükali CI; Ulusoy C; Özkan Ö; Orhan N; Güleç H; Erdağ E; Buker S; Tüzün E
In Vivo; 2015; 29(1):103-8. PubMed ID: 25600537
[TBL] [Abstract][Full Text] [Related]
52. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
53. The role of PON1 and CYP2D6 genes in susceptibility to organophosphorus chronic intoxication in Egyptian patients.
Tawfik Khattab AM; Zayed AA; Ahmed AI; AbdelAal AG; Mekdad AA
Neurotoxicology; 2016 Mar; 53():102-107. PubMed ID: 26723569
[TBL] [Abstract][Full Text] [Related]
54. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
[TBL] [Abstract][Full Text] [Related]
55. Q192R polymorphism of paraoxonase 1 gene associated with insulin resistance in Mexican children.
Alegría-Torres JA; García-Domínguez ML; Cruz M; Aradillas-García C
Arch Med Res; 2015 Jan; 46(1):78-83. PubMed ID: 25500007
[TBL] [Abstract][Full Text] [Related]
56. Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis.
Martínez C; García-Martín E; Benito-León J; Calleja P; Díaz-Sánchez M; Pisa D; Alonso-Navarro H; Ayuso-Peralta L; Torrecilla D; Agúndez JA; Jiménez-Jiménez FJ
Neuromolecular Med; 2010 Sep; 12(3):217-23. PubMed ID: 19826962
[TBL] [Abstract][Full Text] [Related]
57. Impact of null genotypes of GSTT1 and GSTM1 with uterine leiomyoma risk in Iranian population.
Mostafavi SS; Ebrahimi A; Sadat SM; Davari Tanha F; Aghasadeghi MR; Bahramali G; Abbasi Ranjbar P; Sadeghifard V; Javadi F
J Obstet Gynaecol Res; 2016 Apr; 42(4):434-9. PubMed ID: 26785830
[TBL] [Abstract][Full Text] [Related]
58. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate.
Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T
Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910
[TBL] [Abstract][Full Text] [Related]
59. The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis.
Hashemi MM; Mousavi E; Arab-Bafrani Z; Nezhadebrahimi A; Marjani A
Diabetes Res Clin Pract; 2019 Jun; 152():135-145. PubMed ID: 31102685
[TBL] [Abstract][Full Text] [Related]
60. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.
Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G
Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
